Royalty Pharma RPRX
NASDAQ RPRX
$65.93 +1.11 (+1.71%)
At close: Oct 29, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Long-Term Debt Repayments (2019 - 2020)

Updated

Royalty Pharma (RPRX) recorded Long-Term Debt Repayments of $1 billion in FY2025.

Analysis

Royalty Pharma (RPRX) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends

  • Annual Long-Term Debt Repayments has a five-year compound annual growth rate of -38.2% (FY2020 to FY2025).
  • Per Business Quant data, RPRX's Long-Term Debt Repayments was $1 billion in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Orix 40.99 Bn 9.71 Bn 12.74 Bn -
2 Rocket Companies 35.89 Bn 35.89 Bn - -
3 Royalty Pharma 29.95 Bn 26.91 Bn - -
4 Federal National Mortgage Association Fannie Mae 26.64 Bn 26.64 Bn - 148.45 Bn
5 Affirm Holdings 24.55 Bn 18.24 Bn - 9.80 Bn
6 Synchrony Financial 24.01 Bn -43.61 Bn - 1.50 Bn
7 Royal Gold 19.26 Bn 18.43 Bn 390.45 Mn 200.00 Mn
8 Annaly Capital Management 13.94 Bn 4.90 Bn - 5.44 Bn
9 Ares Capital 13.71 Bn 11.46 Bn - 4.01 Bn
10 Federal Home Loan Mortgage 13.42 Bn 13.42 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 5.95 Bn
Jun 30, 2020 47.10 Mn
Mar 31, 2020 5.22 Bn
Dec 31, 2019 73.50 Mn
Sep 30, 2019 73.50 Mn
API Access

Royalty Pharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=RPRX&period=max&api_key=YOUR_API_KEY